Moebius Syndrome in the Hospital Apoyo Iquitos. Possible Cause by Exposure to Misoprostol. Report of one Case
DOI:
https://doi.org/10.61651/rped.2014v67n1p32-37Keywords:
Misoprostol, Mobius SyndromeAbstract
We describe a newborn patient affected with Moebius Syndrome whose mother used Misoprostol for abortive purpose at the ninth week of pregnancy, by taking two tablets (400ug) through the oral tract and applying three tablets (600ug) in the vagina without cause miscarriage. It is describe the clinical profile of a patient as well as his evolution up to the discharge day. Also, clinical findings in our patient are compared with cases described in literature. Several hypotheses are postulated concerning the Syndrome’s ethiopathogenesis and its probable association with the use of Misoprostol (Citotec®) during the first trimester of pregnancy with abortive purpose. Misoprostol has been described as responsible of vascular disruption, secondary to its uterus tonic effects with alteration of fetal blood flow which causes hypoxia and hemorrhage.
Downloads
Downloads
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors will retain the copyright and grant the right to publish their work in the journal while allowing third parties to share it under the Creative Commons Attribution license.
Articles are published under a Creative Commons license that allows sharing and adaptation with appropriate credit. CC BY 4.0 license. Available in English at https://creativecommons.org/licenses/by/4.0/
Authors may use other information disclosure formats as long as the initial publication in the journal is cited. The dissemination of the work through the Internet is recommended to increase citations and promote academic exchanges.
The published content does not necessarily reflect the specific point of view of the journal, and the authors assume full responsibility for the content of their article.
